Free
Meeting Abstracts  |   December 1999
Diaspirin Cross-linked Hemoglobin Effectively Restores Pancreatic Microcirculatory Failure in Hemorrhagic Shock 
Author Affiliations & Notes
  • Ernst von Dobschuetz
    *
  • Tomas Hoffmann, M.D.
  • Konrad Messmer, M.D.
  • *Candidate of Medicine, Institute for Surgical Research, Klinikum Groβhadern, Ludwig-Maximilians-University. †Associate Professor, Maria-Theresia Klinik. ‡Professor, Institute for Surgical Research, Klinikum Groβhadern, Ludwig-Maximilians-University.
Article Information
Meeting Abstracts   |   December 1999
Diaspirin Cross-linked Hemoglobin Effectively Restores Pancreatic Microcirculatory Failure in Hemorrhagic Shock 
Anesthesiology 12 1999, Vol.91, 1754. doi:
Anesthesiology 12 1999, Vol.91, 1754. doi:
ArticlePlus 
Click on the links below to access all the ArticlePlus for this article.
Please note that ArticlePlus files may launch a viewer application outside of your web browser.
SEVERE hemorrhagic shock is characterized by inadequate microcirculatory perfusion and subsequent reperfusion, altered cell membrane permeability, subsequent organ failure caused by cellular dysfunction, and reaction of the immune system. 1 The recovery of macrohemodynamics and the fast restoration of microvascular perfusion and oxygen supply to vital organs are the major aims of primary shock therapy. The oxygen-carrying blood substitute diaspirin cross-linked hemoglobin (DCLHb) is free from immunogenicity in humans 2 and has lower risks of infections compared with homologous blood. 3 Hypoperfusion of the pancreas and consecutive ischemia–reperfusion damage of the organ are considered to be the main causes of acute pancreatitis that occur in patients after hemorrhagic shock. 4,5 Another hallmark of this postischemic organ injury is the generation of oxygen free radicals produced by activated leukocytes 6 and xanthine oxidase 7 during the process of reperfusion. These radicals are implicated in several toxic pathways, including lipid peroxidation and damage of DNA. 8 Cell-free hemoglobin could also be the source of deleterious oxygen free radicals when administered as a resuscitation fluid after hemorrhagic shock. 9 In animals and humans, 10,11 DCLHb produces an elevation of mean arterial pressure (MAP), which is probably caused by its nitric oxide (NO)–scavenging 12 and endothelin-1–releasing 13 properties. Endothelin is known to reduce pancreatic perfusion. 14 The vasoactive effects of DCLHb could influence microcirculatory shock-induced damage to the pancreas. No studies relevant to shock-related pathology have investigated alterations of capillary perfusion and leukocyte adherence by DCLHb treatment in splanchnic organs after hemorrhage. Therefore, the objective of this study was to investigate the effects of DCLHb on the microhemodynamics, leukocyte adherence, and degree of lipid peroxidation of the rat pancreas in comparison with resuscitation with whole blood (WB) and a non–oxygen-carrying colloid solution after hemorrhagic shock.
Materials and Methods 
Anesthesia and Monitoring 
The experimental protocol of this study was approved by the ethical governmental committee of Oberbayern and conforms to the guiding principles in the Care and Use of Animals, as approved by the Council of the American Physiologic Society. Male Sprague-Dawley rats (Charles River, Sulzfeld, Germany) weighing 180–260 g were anesthetized with ether and pentobarbital (50 mg/kg body weight intraperitoneally) after an overnight fast with free access to tap water. After tracheotomy, respiration was volume controlled (frequency: 57–65 breaths/min; tidal volume: 2–2.5 ml; fraction of inspired oxygen [FIO2]: 0.25–0.40, Harvard Rodent Ventilator 683; Harvard Apparatus, South Natick, MA). The right carotid artery and the right jugular vein were cannulated with a polyethylene catheter (PE-50, 0.58 mm ID, Portex, Hythe, Kent, UK) for continuous monitoring of MAP and heart rate. Rectal temperature was kept between 36.5 and 37.5°C by means of a heating pad (Firma Effenberger, Pfaffing, Germany). Adequate anesthesia was maintained by intravenous infusion of pentobarbital (12 mg · kg body weight−1· h−1) and nitrous oxide admixture (0.65–0.75) in the inspired gas. Arterial blood gases, acid–base status, and blood lactate concentration were measured intermittently by a blood gas analyzer (Ciba Corning 860; Chiron diagnostics GmbH, Fernwald, Germany) and were adjusted to the following values for baseline conditions by means of ventilator adjustment and intravenous injection of 8.4% sodium bicarbonate: partial pressure of oxygen (PO2): 100–120 mmHg; partial pressure of carbon dioxide (PCO2): 30–40 mmHg; pH: 7.39 ± 0.02; and base excess: 0 ± 2 mM. During the experiment, arterial PO2was kept above 90 mmHg by alteration of FIO2(shown as arterial oxygen tension (PaO2)/FIO2ratio) and PCO2was kept below 45 mmHg by alteration of the breathing frequency. Hematocrit in arterial blood was measured using a Coultercounter T540 (Coulter Electronics, Hialeah, FL).
Animal Model and Experimental Protocol 
The hemorrhagic shock model used in the current study is a well-established model of fixed-pressure hemorrhage. 15 After recording of baseline values, blood was withdrawn via  the arterial catheter to decrease the MAP to 40 mmHg within 10 min. Blood pressure was controlled at 40 mmHg for 60 min by further withdrawal of blood if necessary. After this shock interval, animals were randomly assigned to one of the following resuscitation groups:(1) 6% hydroxyethylstarch solution (n = 7);(2) 10% DCLHb solution (n = 7);(3) WB (n = 7). (4) Sham-operated animals without induction of hemorrhagic shock served as the control group (n = 7). Shock animals were resuscitated by means of intravenous infusion of the aforementioned solutions in volumes equivalent to the shed blood volume administered over 7 min. The dose of DCLHb (100% of shed volume) has proven its effectiveness in several hemorrhagic shock experiments in rats. 16,17 After resuscitation and a 15-min stabilization period, animals underwent transverse laparotomy for exteriorization of the pancreas and spleen. The organs were placed on an adjustable microscope stage; both organs were covered by a thin transparent plastic membrane to prevent drying. To prevent cooling of the organs, the whole animal and the stage were covered by swabs between the microscopy measurements. MAP was continuously registered on a recorder (Siemens XT Kompensograph, Siemens, Munich, Germany). Heart rate was obtained from the phasic blood pressure curves. Heart rate, arterial blood gases, lactate concentration, and hematocrit were measured at baseline conditions, at the end of shock, and at 15, 60, and 120 min after administration of the solutions. The experiments were discontinued by intravenous injection of an overdose of pentobarbital.
Drugs and WB Preparation 
Hydroxyethylstarch, 6%, 200,000/0.5 (oncotic pressure: 36 mmHg, isotonic in 0.9% NaCl solution) was purchased from Fresenius AG (Bad Homburg, Germany). DCLHb was provided by Baxter Healthcare Corp. (Round Lake, IL; lot number 97J10AD11–111997). According to the manufacturer, 250 ml DCLHb contains 25 g hemoglobin, 1.425 g NaCl, 0.950 g sodium DL-lactate, 0.075 g KCl, 0.0325 g calcium chloride, 0.010 g magnesium chloride, water for injections to a volume of 250 ml. methemoglobin concentration was less than 5%; P50was 32 mmHg; pH was adjusted to 7.4 at 37°C; oncotic pressure was 42 mmHg. Containers were stored in a −70°C freezer and thawed 0.5 h before use. The animals in the WB group received their autologous shed blood, which was drawn into a syringe containing CPDA-1 in the same mixture relation as in donation packs (63 ml CPDA-1/450 ml blood). CPDA-1 was withdrawn from original packs provided for blood donations (Baxter S.A., Maurepas, France).
Intravital Microscopy and Quantification of Microvascular Parameters 
Hydroxyethylstarch, 0.75%, 0.15 ml, (molecular weight 200,000 d), labeled with the fluorochrome fluorescein isothiocyanate (Laevosan, Linz, Austria) for contrast enhancement of microvessels and 0.1 ml Rhodamin 6G, 0.2%, (molecular weight 497; Sigma. St Louis, MO) for in vivo  staining of cytochrome C–containing cells (leukocytes) were injected intravenously in the right jugular vein before the first microcirculatory measurement time point. Intravital microscopy of the pancreas was performed using a modified Leitz-Orthoplan microscope (Leitz, Wetzlar, Germany) with a mercury lamp (100 W, HBO) attached to a Ploemo-Pak illuminator (Leitz) with I2/3(excitation 450–490 nm, emission greater than 515 nm, used for leukocyte adherence) and N2(excitation 530–560 nm, emission greater than 580 nm, used for functional capillary density [FCD]) filter blocks (Leitz) for epiillumination. A saltwater immersion objective (SWX25/0.6; Leitz) allowed magnification of approximately 800×. The observations were recorded by means of a charge-coupled device (CCD) video camera (FK 6990; Cohu, Prospective Measurements, San Diego, CA) and stored on video tape (video recorder; AG-Panasonic, Munich, Germany) for off-line evaluation. Quantitative assessment of the microcirculation included determination of the FCD and the number of adherent leukocytes in the postcapillary venules. These parameters were measured at three time points: 45, 90, and 120 min after injection of the solutions. FCD  is defined as the length of erythrocyte-perfused capillaries (cm) per observation area (cm2). 18 The FCD, as determined by analysis of the video tapes according to Schmid-Schönbein 19 by means of superimposing a grid (squared-type) on the video screen (square side, 50 μm). The number of intersections of erythrocyte-perfused capillaries with the grid system were counted, and FCD was calculated using the following two formulas:20 FCD = Lc9=π/2 × Nc/L; L = 2 × P × d; where Lc is the length of perfused capillaries, Nc is the number of intersections, P is the number of squares of the grid, d is the length of the edge of the grid. Ten randomly selected regions of interest (400 × 300 μm) of the pancreas were evaluated at each time point. For quantification of leukocyte–endothelial interaction, at least three postcapillary venules (diameter < 40 μm and < 150 μm length) per animal were recorded for 30 s at each time point. Adherent leukocytes were defined as cells remaining stationary on the surface of the endothelium for the whole observation time of 30 s. The surface area of the vessel segments was calculated based on diameter measurement assuming a cylindrical geometry of the vessels. Adherent leukocytes are given as cells/endothelial surface (cells/mm2).
Measurement of Lipid Peroxidation in Pancreatic Tissue 
Lipid peroxidation of pancreatic tissue was quantified by an assay that measured the thiobarbituric acid–reactive materials (TBARMs). 21 Pancreatic tissue was harvested and shock-frozen immediately after the end of the experiments. Samples were stored in a −70° freezer until analysis. Before analysis, samples were cut by a shaving knife into small pieces. 10 ml KCl solution, 1.1%, was mixed with 1 g pancreatic tissue. The suspension was homogenized at 1,200 rpm for 5 min (homogenisator; Braun, Melsungen, Germany). The homogenate was immediately analyzed photometrically.
Light microscopy 
Tissue samples from the corpus of the pancreas were taken at the end of the experiment and immediately fixed in 10% neutral-buffered formalin. The samples were dehydrated, embedded in paraffin, cut at approximately 3 μm (Microtome; Leica, Munich, Germany), and stained with hematoxylin and eosin. One tissue section/animal was evaluated by a blinded observer for edema, inflammation (infiltration of granulocytes), parenchymal necrosis, and hemorrhage.
Statistical Analysis 
All data are presented as the mean values ± SD. Data analysis was performed using a statistical software package (STATISTICA; StatSoft GmbH, Hamburg, Germany). Statistical comparison was performed by a two-way analysis of variance (one-way in TBARMs) followed by a Student–Newman–Keuls test. P  < 0.05 was considered to be statistically significant.
Results 
Macrohemodynamics and Hematocrit and Hemoglobin Concentrations 
The volume of withdrawn blood during shock was 6.6 ± 0.8 ml, 8.1 ± 0.8 ml, and 8.4 ± 1.0 ml in the hydroxyethylstarch, DCLHb, and WB groups, respectively. DCLHb and WB restored MAP to the values of the control group immediately after injection (fig. 1). Hydroxyethylstarch resulted in a significantly lower MAP after resuscitation compared with control, DCLHb, and WB animals. There were no significant differences in heart rate among the three experimental groups (table 1). The hematocrit values of the DCLHb and hydroxyethylstarch groups were significantly lower than the values in the control and WB groups during the resuscitation time. During shock, the hematocrit value in the hydroxyethylstarch group was significantly higher compared with the DCLHb and WB groups. However, hydroxyethylstarch resuscitation 15 min after injection resulted in a significantly lower hematocrit value than did DCLHb. DCLHb resuscitation showed significantly higher hemoglobin concentrations during resuscitation compared with hydroxyethylstarch.
Fig. 1. Changes of mean arterial pressure (MAP) during 1 h hemorrhagic hypotension and resuscitation time. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, DCLHb, and WB;§  P  < 0.05 is significant  versus  baseline. 
Fig. 1. Changes of mean arterial pressure (MAP) during 1 h hemorrhagic hypotension and resuscitation time. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, DCLHb, and WB;§  P  < 0.05 is significant  versus  baseline. 
Fig. 1. Changes of mean arterial pressure (MAP) during 1 h hemorrhagic hypotension and resuscitation time. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, DCLHb, and WB;§  P  < 0.05 is significant  versus  baseline. 
×
Table 1. The Effect of DCLHb on Heart Rate, Hematocrit, and Hemoglobin 
Image not available
Table 1. The Effect of DCLHb on Heart Rate, Hematocrit, and Hemoglobin 
×
Functional Capillary Density 
Functional capillary density was significantly reduced in all resuscitation groups compared with the control group during the whole observation time (fig. 2). Two hours after injection, FCD was restored to 66 (P  < 0.0002 vs.  control), 80 (P  < 0.003) and 84%(P  < 0.012) of control values (366 ± 28 cm−1) by hydroxyethylstarch, DCLHb, and WB resuscitation, respectively. At the end of the experiment, FCD was significantly higher in the DCLHb (P  < 0.04) and WB (P  < 0.01) animals compared with the hydroxyethylstarch-resuscitated animals. There was no significant difference of FCD between the DCLHb and WB groups during the experimentation.
Fig. 2. Functional capillary density (length of erythrocyte-perfused capillaries per area) of pancreatic acini after resuscitation. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, *  P  < 0.05 is significant  versus  hydroxyethylstarch;§  P  < 0.05 is significant  versus  WB; no significant changes within each group. 
Fig. 2. Functional capillary density (length of erythrocyte-perfused capillaries per area) of pancreatic acini after resuscitation. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, *  P  < 0.05 is significant  versus  hydroxyethylstarch;§  P  < 0.05 is significant  versus  WB; no significant changes within each group. 
Fig. 2. Functional capillary density (length of erythrocyte-perfused capillaries per area) of pancreatic acini after resuscitation. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, *  P  < 0.05 is significant  versus  hydroxyethylstarch;§  P  < 0.05 is significant  versus  WB; no significant changes within each group. 
×
Leukocyte–Endothelium Interaction 
Hydroxyethylstarch-treated animals showed a significant (P  < 0.01) 4.1-fold increase of leukocyte adherence in postcapillary pancreatic venules compared with the control group (149 ± 111 cells/mm2) at the end of the experiment (fig. 3). Although there is an elevation of leukocyte adherence in all other resuscitation groups, the values were not significantly different at any time point among the groups or within each group during the three measurements.
Fig. 3. Number of adherent leukocytes (“stickers”) in postcapillary venules. Values are expressed as the mean ± SD. #  P  < 0.05  versus  control, no other significances between the groups at each time point or within each group were detected. 
Fig. 3. Number of adherent leukocytes (“stickers”) in postcapillary venules. Values are expressed as the mean ± SD. #  P  < 0.05  versus  control, no other significances between the groups at each time point or within each group were detected. 
Fig. 3. Number of adherent leukocytes (“stickers”) in postcapillary venules. Values are expressed as the mean ± SD. #  P  < 0.05  versus  control, no other significances between the groups at each time point or within each group were detected. 
×
Fig. 4. Pancreatic tissue concentration of thiobarbituric acid–reactive materials (TBARMs) as a parameter of lipid peroxidation damage. No significant difference was detected between the DCLHb and the WB group. Values are expressed as the mean ± SD. *  P  < 0.05 is significant  versus  control and hydroxyethylstarch. 
Fig. 4. Pancreatic tissue concentration of thiobarbituric acid–reactive materials (TBARMs) as a parameter of lipid peroxidation damage. No significant difference was detected between the DCLHb and the WB group. Values are expressed as the mean ± SD. *  P  < 0.05 is significant  versus  control and hydroxyethylstarch. 
Fig. 4. Pancreatic tissue concentration of thiobarbituric acid–reactive materials (TBARMs) as a parameter of lipid peroxidation damage. No significant difference was detected between the DCLHb and the WB group. Values are expressed as the mean ± SD. *  P  < 0.05 is significant  versus  control and hydroxyethylstarch. 
×
Acid–Base Balance, PO2/FIO2Ratio, Blood Lactate 
The bolus injection of DCLHb resulted in a rapid need to increase FIO2by at least 20% to maintain normal arterial PO2blood gas values during the first 15 min after infusion. This resulted in a significant (P  < 0.0003) reduction of the PO2/FIO2ratio, compared with the other groups (table 2). Shock increased negative base excess and blood lactate concentration significantly (P  < 0.05) in all groups, compared with the control group. DCLHb improved recovery from acidosis more effectively than hydroxyethylstarch resuscitation at the end of the observation time. There were no significant differences of blood lactate concentration at any time after resuscitation in the three experimental groups.
Table 2. The Effect of Resuscitation on PaO2/FIO2Ratio, Acid–Base Balance, and Blood Lactate Concentration 
Image not available
Table 2. The Effect of Resuscitation on PaO2/FIO2Ratio, Acid–Base Balance, and Blood Lactate Concentration 
×
Thiobarbituric Acid–reactive Materials Concentration in Pancreatic Tissue 
Thiobarbituric acid–reactive materials tissue concentration, as a parameter of peroxidative tissue injury, was measured 2 h after resuscitation. TBARMs could not be detected in the control group, but were detected at lower levels in the hydroxyethylstarch-treated group (fig. 4). Resuscitation with both oxygen-carrying solutions, DCLHb and WB, resulted in a significant (P  < 0.05) increase of TBARMs concentration (4.8 ± 0.7 and 3.7 ± 0.7 nmol/g, respectively) compared with the control and hydroxyethylstarch-treated group, without significant differences between these two groups. Histopathologic changes (edema, necrosis, cell infiltration, and hemorrhage) were absent in all three shock groups and the control group.
Discussion 
The results of this study indicate that DCLHb as an oxygen-carrying resuscitation fluid restores systemic MAP and pancreatic capillary perfusion as effectively as does resuscitation with WB. Although there was a higher amount of lipid peroxidation damage of the pancreatic tissue after resuscitation with the oxygen carriers DCLHb and WB, compared with hydroxyethylstarch, probably because of the initiation of reperfusion damage, both oxygen carriers were found to restore capillary perfusion better than did hydroxyethylstarch resuscitation. DCLHb did not enhance the degree of leukocyte adherence in postcapillary venules or the degree of pancreatic lipid peroxidation, compared with WB resuscitation.
The oxygen-carrying properties of DCLHb have been shown in many experimental studies. 22,23 However, the phase III trial in trauma patients recently was discontinued prematurely because of a higher mortality in the treatment group. 24 In clinical phase I and II studies, DCLHb increased MAP after infusion in a dose-independent manner, indicating that the human pressor response to DCLHb is similar to the response observed in preclinical studies. 10,11 This pressor effect was also observed in other hemoglobin-based oxygen-carrying solutions. 25 Although the main mechanisms of pressor actions of DCLHb are not completely clear, the NO-scavenging property of cell-free hemoglobin appears to be directly involved. Clinical investigations showed a threefold elevation of the potent vasoconstrictor endothelin-1 concentration after DCLHb infusion in stroke patients without affecting other vasoactive mediators. 26 There is speculation that the higher endothelin concentration at infusion of DCLHb is caused by the DCLHb-induced lowering of nitric oxide because there is a close balance between the endothelium-derived relaxation by NO and the endothelium-derived constriction factor endothelin-1. 27 
Effect of Resuscitation on the Microcirculation 
The pancreatic tissue damage in hemorrhagic shock is considered to be mainly caused by the ischemia that occurs during hemorrhagic shock and the ongoing microcirculatory failure during reperfusion, although the macrocirculation was restored sufficiently by resuscitation. 4,5,28 Elevation of endothelin and NO-scavenging involved in treatment with DCLHb could have multiple effects on the microcirculation of the pancreas. Endothelin-1, when infused into anesthetized dogs, has proven to reduce pancreatic blood flow. 14 In hamster skin muscle, DCLHb resulted in a 25% reduction of FCD after hemorrhagic shock, compared with control values. 25 After 1 h of normothermic pancreatic ischemia, DCLHb did not alter microvascular perfusion failure. 29 So far, there exist only data of DCLHb effects on the splanchnic blood flow, as investigated by the microsphere technique after hemorrhagic shock. 30 Because there could be arteriovenous shunting in the pancreas, 31 using this technique to assess blood flow to splanchnic organs does not show information about nutritive supply to the pancreas that occurs on the capillary level of microcirculation, which is gained by using an intravital microscopy technique. FCD is an index of the quality of capillary perfusion and has proven to be a predictor of survival after severe hemorrhagic shock. 32 The number of erythrocyte-perfused capillaries is critical for the vitality of an organ after shock and ischemia–reperfusion damage regarding nutritive and metabolite extracting properties. 33 Infusion of DCLHb showed an enhancement of blood flow to the gastrointestinal system during normal conditions 30 and after hemorrhagic shock. 17 Our study proved that DCLHb as a resuscitation fluid restores capillary perfusion of the pancreas as effectively as WB. Although hydroxyethylstarch resuscitation resulted in comparable hematocrit values, as obtained after infusion of DCLHb (indicating similar volume expanding properties), the restoration of capillary perfusion was more effective with the oxygen-carrying hemoglobin solution in contrast with hydroxyethylstarch resuscitation.
Effect of Resuscitation on Leukocyte–Endothelium Interaction 
Activation of leukocytes is a crucial hallmark of the immunologic response after hemorrhagic shock. In the pancreas microcirculation, depletion of granulocytes resulted in a significant reduction of capillary no-reflow in an experimental study of hemorrhagic shock. 6 Application of monoclonal antibodies against the neutrophil adhesion molecule CD18 in a primate model of hemorrhagic shock reduced the resuscitation volume requirement and improved survival. 34 These findings highlight the crucial effect of adherence and activation of leukocytes in the pathophysiology of hemorrhagic shock. Leukocyte adherence was significantly elevated compared with that in the control group only 120 min after hydroxyethylstarch infusion. DCLHb showed an elevation of leukocyte adherence of resuscitation that was not more pronounced than in the other resuscitation groups, indicating that DCLHb does not enhance the inflammatory reaction, compared with WB resuscitation.
Effect of Resuscitation on Breathing Adjustment 
After resuscitation with DCLHb a much higher FIO2was needed for maintenance of normal PaO2. This need was indicated by a significant decrease of the PaO2/FIO2ratio 15 min after DCLHb infusion, compared with all other groups. We interpret this finding as an NO-dependent increase of pulmonary pressure after DCLHb infusion. 35 
Effect of Resuscitation on Lipid Peroxidation 
One of the main events of ischemia–reperfusion damage that occurs in hemorrhagic shock is the generation of oxygen radicals. They are able to provide up-regulation of leukocyte adhesion molecules and damage nucleic acids and can deactivate important enzymes and peroxidase in cell membrane lipids. 8 Antioxidant treatment with vitamin E and superoxide dismutase has proven to be beneficial after hemorrhagic shock 36 and ischemia–reperfusion. 37 In the inflammatory process of hemorrhagic shock, several sources generate oxygen radicals, such as the xanthine oxidase, the oxidative burst of activated granulocytes, and the reaction of nitric oxide with superoxide anion to form peroxynitrite. Additionally, in our study free hemoglobin could act as a Fenton reagent with the potential to catalyze hydroxyl radical generation by autooxidation of the hemoglobin heme iron atom to methemoglobin. 9 All these radicals can initiate peroxidation of polyunsaturated fatty acids of cell membranes. Lipid peroxidation products such as malondialdehyde represent highly active aldehydes with their own spectrum of toxicity. Measurement of lipid peroxidation is used as an indirect quantitative measurement of reactive oxygen radical generation. 38 Pancreatic levels of malondialdehyde, one of the main degradation products of oxidatively peroxidized lipids, can be measured as TBARMs. It is unclear whether TBARMs are very specific markers of lipid peroxidation because other substances, such as bilirubin, can react with thiobarbituric acid. 39 The test we used showed a negligible interference with bilirubin. 21 In our study, no enhanced production of oxygen radicals by DCLHb, compared with the WB resuscitation, could be detected. Hemodilution with DCLHb after induction of kidney ischemia–reperfusion did not enhance radical generation. 40 Furthermore, DCLHb has proven its usefulness in the treatment of systemic 41 and organ ischemia in animal in vivo  models of the heart, 42 skin muscle, 43 and the brain, 44,45 suggesting an absence of further generation of oxygen radicals. Although lipid peroxidation is significantly higher after resuscitation with oxygen carriers than after colloid resuscitation, hydroxyethylstarch did not reverse capillary perfusion deficit, indicating a lower potential to restore microvascular perfusion with the oxygen-carrying solutions.
In conclusion, our study showed a similar restoration of macrocirculatory parameters by a hemoglobin-based oxygen carrier, compared with WB resuscitation, after hemorrhagic shock. DCLHb did not exacerbate the adherence of leukocytes in postcapillary pancreatic venules compared with the other solutions. Most importantly, the capillary perfusion of the pancreas was restored to values seen after WB resuscitation. There was an increased need of oxygen to maintain oxygen saturation after DCLHb infusion. DCLHb did not cause enhanced lipid peroxidation of pancreatic tissue compared with WB resuscitation. Thus, DCLHb was as effective as WB resuscitation fluid in our experimental model.
The authors thank Steffen Massberg, Tadashi Kondo, and Christine Cappo for their advice and technical assistance. Without their help the project could not have been completed.
References 
References 
Peitzman AB, Billiar TR, Harbrecht BG, Kelly E, Udekwu AO, Simmons RL: Hemorrhagic shock. Curr Probl Surg 1995; 32: 925–1002
Patel MJ, Webb EJ, Shelbourn TE, Mattia-Godberg C, George AJT, Zhang F, Moore EG, Nelson D: Absence of immunogenicity of Diaspirin cross-linked hemoglobin in humans. Blood 1998; 91: 710–6
Farmer M, Ebeling A, Marshall T, Hauck W, Sun CS, White E, Long Z: Validation of virus inactivation by heat treatment in the manufacture of diaspirin crosslinked hemoglobin. Biomater Artif Cells Immobilization Biotechnol 1992; 20: 429–33
Klar E, Messmer K, Warshaw AL, Herfarth C: Pancreatic ischemia in experimental acute pancreatitis: Mechanism, significance, therapy. Br J Surg 1990; 77: 1205–10
Warshaw AL, O'Hara PJ: Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978; 188: 197–201
Barroso-Aranda J, Schmid-Schönbein GW, Zweifach BW, Engler RL: Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock. Circ Res 1988; 63: 437–47
Hotter G, Closa D, Gelpi E, Prats N, Rosello Catafau J: Role of xanthine oxidase and eicosanoids in development of pancreatic ischemia-reperfusion injury. Inflammation 1995; 19: 469–78
Flowers F, Zimmerman JJ: Reactive oxygen species in the cellular pathophysiology of shock. New Horiz 1998; 6: 169–80
Sadrzadeh SM, Graf E, Panter SS, Hallaway PE, Eaton JW: Hemoglobin. A biologic fenton reagent. J Biol Chem 1984; 259: 14354–6
Reah G, Bodenham AR, Mallick A, Daily EK, Przybelski RJ: Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients. Crit Care Med 1997; 25: 1480–8
Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colburn WA: Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 1996; 24: 1993–2000
Sharma AC, Singh G, Gulati A: Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am J Physiol 1995; 269: H1379–88
Gulati A, Sharma AC, Singh G: Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin. Crit Care Med 1996; 24: 137–47
Takaori K, Inoue K, Kogire M, Higashide S, Tun T, Aung T, Doi R, Fujii N, Tobe T: Effects of endothelin on microcirculation of the pancreas. Life Sci 1992; 51: 615–22
Vollmar B, Preissler G, Menger M: Small-volume resuscitation restores hemorrhage-induced microcirculatory disorders in rat pancreas. Crit Care Med 1996; 24: 445–50
Schultz SC, Hamilton IN Jr, Malcolm DS: Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. J Trauma 1993; 35: 619–25
Gulati A, Sen A: Dose-dependent effect of diaspirin cross-linked hemoglobin on regional blood circulation of severely hemorrhaged rats. Shock 1998; 9: 65–73
Nolte D, Zeintl H, Steinbauer M, Pickelmann S, Messmer K: Functional capillary density: An indicator of tissue perfusion? Int J Microcirc Clin Exp 1995; 15: 244–9
Schmid-Schönbein GW, Zweifach BW, Kovalcheck S: The application of stereological principles to morphometry of the microcirculation in different tissues. Microvasc Res 1977; 14: 303–17
Hoffmannn TR, Leiderer R, Waldner H, Arbogast S, Messmer K: Ischemia reperfusion of the pancreas: A new in vivo model for acute pancreatitis in rats. Res Exp Med Berl 1995; 195: 125–44
Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–8
Sielenkämper AW, Chin Yee IH, Martin CM, Sibbald WJ: Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats. Am J Respir Crit Care Med 1997; 156: 1066–72
Nelson D: Blood and HemAsisst (DCLHb): Potentially a complementary therapeutic team, Blood Substitutes: Principles, Methods, Products and Clinical trials. Edited by Chang TMS. Basel, Karger, 1997, pp 39–61
Saxena R: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999; 30: 993–6
Ulatowski JA, Nishikawa T, Matheson-Urbaitis B, Bucci E, Traystman RJ, Koehler RC: Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med 1996; 24: 558–65
Saxena R, Wijnhoud AD, Man in't Veld AJ, van den Meiracker AH, Boomsma F, Przybelski RJ, Koudstaal PJ: Effect of diaspirin cross-linked hemoglobin on endothelin-1 and blood pressure in acute ischemic stroke in man. J Hypertens 1998; 16: 1459–65
Rubanyi GM, Polokoff MA: Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325–415
Hoffmann TF, Leiderer R, Harris AG, Messmer K: Ischemia and reperfusion in pancreas. Microsc Res Tech 1997; 37: 557–71
von Dobschuetz E, Hoffmann T, Engelschalk C, Messmer K: Effect of diaspirin cross-linked hemoglobin on normal and postischemic microcirculation of the rat pancreas. Am J Physiol 1999; 276: G1507–14
Gulati A: Effect of diaspirin crosslinked hemoglobin on systemic and regional blood circulation, Tissue Oxygenation in Acute Medicine. Edited by Sibbald WJ, Messmer K, Fink MP. New York, Springer, 1998, pp 307–17
Menger MD, Vollmar B: In vivo documentation of an arteriovenous shunt in rat pancreatic acinar tissue. Pancreas 1996; 13: 125–9
Kerger H, Saltzman DJ, Menger MD, Messmer K, Intaglietta M: Systemic and subcutaneous microvascular PO2 dissociation during hemorrhagic shock in conscious hamsters. Am J Physiol 1996; 70: H827–36
Tsai AG, Kerger H, Intaglietta M: Oxygen distribution and consumption by the microcirculation and the determinants of tissue survival, Tissue Oxygenation in Acute Medicine. Edited by Sibbald WJ, Messmer K, Fink MP. New York, Springer, 1998, pp 55–62
Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL: Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 1990; 108: 206–12
Sefton W, Pudimat P, Bina S, Lojeski E, Mongan P, Muldoon S: Inhaled nitric oxide attenuates increased pulmonary artery pressure following diaspirin crosslinked hemoglobin (DCLHB) administration. Artif Cells Blood Substit Immobil Biotechnol 1999; 27: 203–13
Youn YK, LaLonde C, Demling R: Use of antioxidant therapy in shock and trauma. Circ Shock 1991; 35: 245–9
Lehr HA, Vajkoczy P, Menger MD: Vitamin E: Focus on microcirculation. Microcirculation 1998; 5: 117–28
Gutteridge JM: Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819–28
Knight JA, Pieper RK, McClellan L: Specificity of the thiobarbituric acid reaction: Its use in studies of lipid peroxidation. Clin Chem 1988; 34: 2433–8
Pincemail J, Detry O, Philippart C, Defraigne JO, Franssen C, Burhop K, Deby C, Meurisse M, Lamy M: Diaspirin crosslinked hemoglobin (DCLHb): Absence of increased free radical generation following administration in a rabbit model of renal ischemia and reperfusion. Free Radic Biol Med 1995; 19: 1–9
Nolte D, Botzlar A, Pickelmann S, Bouskela E, Messmer K: Effects of diaspirin-cross-linked hemoglobin (DCLHb) on the microcirculation of striated skin muscle in the hamster: A study on safety and toxicity. J Lab Clin Med 1997; 130: 314–27
McKenzie JE, Cost E, Scandling DM, Ahle NW, Savage RW: Effects of diaspirin crosslinked haemoglobin during coronary angioplasty in the swine. Cardiovasc Res 1994; 28: 1188–92
Pickelmann S, Nolte D, Leiderer R, Schütze E, Messmer K: Attenuation of postischemic reperfusion injury in striated skin muscle by diaspirin-cross-linked Hb. Am J Physiol 1998; 275: H361–8
Cole DJ, Nary J, Reynolds LW, Patel P, Drummond JC: Experimental subarachnoid hemorrhage in rats: Effect of intravenous alpha-alpha diaspirin crosslinked hemoglobin on hypoperfusion and neuronal death. A NESTHESIOLOGY 1997; 87: 1486–93
Cole DJ, Schell RM, Drummond JC, Reynolds L: Focal cerebral ischemia in rats. Effect of hypervolemic hemodilution with diaspirin cross-linked hemoglobin versus albumin on brain injury and edema. A NESTHESIOLOGY 1993; 78: 335–42
Fig. 1. Changes of mean arterial pressure (MAP) during 1 h hemorrhagic hypotension and resuscitation time. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, DCLHb, and WB;§  P  < 0.05 is significant  versus  baseline. 
Fig. 1. Changes of mean arterial pressure (MAP) during 1 h hemorrhagic hypotension and resuscitation time. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, DCLHb, and WB;§  P  < 0.05 is significant  versus  baseline. 
Fig. 1. Changes of mean arterial pressure (MAP) during 1 h hemorrhagic hypotension and resuscitation time. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, DCLHb, and WB;§  P  < 0.05 is significant  versus  baseline. 
×
Fig. 2. Functional capillary density (length of erythrocyte-perfused capillaries per area) of pancreatic acini after resuscitation. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, *  P  < 0.05 is significant  versus  hydroxyethylstarch;§  P  < 0.05 is significant  versus  WB; no significant changes within each group. 
Fig. 2. Functional capillary density (length of erythrocyte-perfused capillaries per area) of pancreatic acini after resuscitation. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, *  P  < 0.05 is significant  versus  hydroxyethylstarch;§  P  < 0.05 is significant  versus  WB; no significant changes within each group. 
Fig. 2. Functional capillary density (length of erythrocyte-perfused capillaries per area) of pancreatic acini after resuscitation. Values are expressed as the mean ± SD. #  P  < 0.05 is significant  versus  control, *  P  < 0.05 is significant  versus  hydroxyethylstarch;§  P  < 0.05 is significant  versus  WB; no significant changes within each group. 
×
Fig. 3. Number of adherent leukocytes (“stickers”) in postcapillary venules. Values are expressed as the mean ± SD. #  P  < 0.05  versus  control, no other significances between the groups at each time point or within each group were detected. 
Fig. 3. Number of adherent leukocytes (“stickers”) in postcapillary venules. Values are expressed as the mean ± SD. #  P  < 0.05  versus  control, no other significances between the groups at each time point or within each group were detected. 
Fig. 3. Number of adherent leukocytes (“stickers”) in postcapillary venules. Values are expressed as the mean ± SD. #  P  < 0.05  versus  control, no other significances between the groups at each time point or within each group were detected. 
×
Fig. 4. Pancreatic tissue concentration of thiobarbituric acid–reactive materials (TBARMs) as a parameter of lipid peroxidation damage. No significant difference was detected between the DCLHb and the WB group. Values are expressed as the mean ± SD. *  P  < 0.05 is significant  versus  control and hydroxyethylstarch. 
Fig. 4. Pancreatic tissue concentration of thiobarbituric acid–reactive materials (TBARMs) as a parameter of lipid peroxidation damage. No significant difference was detected between the DCLHb and the WB group. Values are expressed as the mean ± SD. *  P  < 0.05 is significant  versus  control and hydroxyethylstarch. 
Fig. 4. Pancreatic tissue concentration of thiobarbituric acid–reactive materials (TBARMs) as a parameter of lipid peroxidation damage. No significant difference was detected between the DCLHb and the WB group. Values are expressed as the mean ± SD. *  P  < 0.05 is significant  versus  control and hydroxyethylstarch. 
×
Table 1. The Effect of DCLHb on Heart Rate, Hematocrit, and Hemoglobin 
Image not available
Table 1. The Effect of DCLHb on Heart Rate, Hematocrit, and Hemoglobin 
×
Table 2. The Effect of Resuscitation on PaO2/FIO2Ratio, Acid–Base Balance, and Blood Lactate Concentration 
Image not available
Table 2. The Effect of Resuscitation on PaO2/FIO2Ratio, Acid–Base Balance, and Blood Lactate Concentration 
×